WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007001065) METHOD FOR THE PREPARATION OF A WET GRANULATED DRUG PRODUCT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/001065    International Application No.:    PCT/JP2006/313174
Publication Date: 04.01.2007 International Filing Date: 26.06.2006
IPC:
A61K 9/16 (2006.01), A61K 9/20 (2006.01), A61K 31/4178 (2006.01), A61K 31/4422 (2006.01), A61P 9/12 (2006.01)
Applicants: DAIICHI SANKYO COMPANY, LIMITED [JP/JP]; 5-1, Nihonbashi Honcho 3-chome, Chuo-ku, Tokyo 1038426 (JP) (For All Designated States Except US).
HAMAURA, Takeshi [JP/JP]; (JP) (For US Only).
KANNO, Mitsuru [JP/JP]; (JP) (For US Only)
Inventors: HAMAURA, Takeshi; (JP).
KANNO, Mitsuru; (JP)
Agent: YAGUCHI, Toshiaki; c/o Daiichi Sankyo Company, Limited, 1-16-3, Kitakasai Edogawa-ku, Tokyo 134-8630 (JP)
Priority Data:
2005-187212 27.06.2005 JP
Title (EN) METHOD FOR THE PREPARATION OF A WET GRANULATED DRUG PRODUCT
(FR) METHODE POUR PREPARER UN PRODUIT MEDICAMENTEUX SE PRESENTANT SOUS FORME DE GRANULES HUMIDES
Abstract: front page image
(EN)The invention relates to a method for the preparation of a solid dosage form comprising an angiotensin II receptor antagonist and a calcium channel blocker, said method comprising a step of preparing by wet granulation a composition comprising said angiotensin II receptor antagonist and said calcium channel blocker. The solid dosage form obtainable by the method of the present invention demonstrates improved dissolution properties.
(FR)L'invention concerne une méthode pour préparer une forme dosifiée solide comprenant un antagoniste du récepteur II d'angiotensine et un bloqueur de canal de calcium. Cette méthode comprend une étape consistant à préparer, par granulation humide, une composition comprenant l'antagoniste du récepteur II d'angiotensine susmentionné et le bloqueur de canal de calcium susmentionné. La forme dosifiée solide de l'invention obtenue par la méthode de l'invention présente des propriétés de dissolution accrues.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)